Amyloid fibrils were isolated from cardiac tissue of two brothers who died from familial amyloidotic polyneuropathy (FAP) type II. Sequence analysis on peptides derived from proteolytic cleavage with trypsin and fragmentation with cyanogen bromide reveal that the fibril subunit protein is derived from plasma transthyretin (prealbumin). About two-thirds of the fibril subunit protein was found to contain an amino acid substitution at position 84 where the normal isoleucine residue has been replaced by serine. Sequence analysis of the plasma transthyretin (prealbumin) from the two brothers as well as two clinically diagnosed FAP type II family members and two of four children of affected individuals showed the presence of serine at position 84. The presence of this substitution also correlates with low serum levels of retinolbinding protein and thus transthyretin (prealbumin) position 84 may be involved with the interaction of these two proteins.
Introduction
In 1956 Rukavina et al. (1) reported a large kindred of Swiss descent with hereditary amyloidosis who had settled in northeastern Indiana. At the time the clinical features of this malady were distinctive from the familial amyloidotic polyneuropathy (FAP)1 in Portuguese families that was described by Andrade (2) . The Indiana/Swiss type ofamyloidosis was characterized by early onset of the carpal tunnel syndrome followed by a more generalized peripheral neuropathy, blindness from vitreous deposits of amyloid, and cardiomyopathy. Unlike the Portuguese FAP, clinically significant renal involvement was absent. While a number ofother kindreds with amyloidosis have been described in the last 30 years (Japanese, Swedish, Danish, Iowa, German, French) (3) (4) (5) (6) (7) (8) , the Indiana/Swiss syndrome has remained clinically distinct. Only the Maryland kindred described by Mah- loudji, which also has a high incidence ofcarpal tunnel syndrome, clinically resembles the Indiana syndrome (7) .
With the discovery that amyloid fibrils in the autosomal dominant amyloidoses were composed of transthyretin (prealbumin), it became obvious that these amyloidoses might be clas-sified chemically (9) . Pras et al. described a variant transthyretin (prealbumin) from the amyloid of a Jewish patient (10) and it is now known that at least one Swedish kindred (1 1, 12) , two Japanese kindreds (13, 14) , and the Portuguese patients with amyloidosis (15) all have a variant transthyretin (prealbumin) with a methionine substitution for valine at position 30 of the 127 amino acid residue transthyretin (prealbumin) molecule.
Recently we found that affected individuals in the Indiana/ Swiss kindred have low serum levels of retinol-binding protein (RBP), whereas other kindreds do not (16) . Since RBP binds to transthyretin (prealbumin) in the plasma, this led us to postulate that another transthyretin (prealbumin) variant is present in this condition. To investigate this we have isolated and structurally characterized the amyloid protein of the Indiana/Swiss type.
Methods
Amyloid-laden tissue was obtained postmortem from two brothers who died of cardiac insufficiency and who had been diagnosed as having FAP type II. Amyloid fibrils were isolated from 30-g samples of heart tissue by the procedure of Pras et al. ( 17) . The fibril subunit protein was then isolated from fibril concentrates by denaturation, reduction, alkylation, and size exclusion chromatography as previously described (12) . The subunit protein (4 mg) was digested with trypsin and the peptides separated by reverse-phase high performance liquid chromatography (HPLC) on a column (1 X 25 cm) of Synchrom RP-8 resin. When necessary, peptides were repurified on Altex Ultrasphere C-18 or Waters bondapakphenyl columns. Polyacrylamide gel electrophoresis (PAGE) was done as previously described (1 1).
The amyloid subunit protein and plasma transthyretin (prealbumin) were cleaved with cyanogen bromide as reported previously (18) . To 2 mg of amyloid subunit protein was added 0.5 ml of deoxygenated 70% formic acid and 2 mg of cyanogen bromide. The mixture was stirred in the dark at room temperature for 24 h and then dried under vacuum. The peptides were dissolved in 0.5 ml of 50% acetic acid and separated by reverse-phase high pressure liquid chromatography on a column (1 X 25 cm) of Synchrom RP-P resin using a 2-propanol gradient (0-56% during 90 min) to elute the peptides.
All protein and peptide samples were degraded in an 890C liquidphase sequenator (Beckman Instruments, Inc., Fullerton, CA) using the 0.1 M Quadrol buffer program. 3 mg of polybrene was added to each sample to reduce extractive losses. Amino acid analyses were performed on a 1 19C instrument (Beckman Instruments, Inc.). All samples were hydrolyzed under vacuum for 24 h at 1 15°C using 5.7 N double-distilled HCO that contained 2 mg of phenol to reduce oxidation.
Plasma transthyretin (prealbumin) was isolated using a three-step procedure involving DEAE Sephadex ion exchange chromatography, Affigel Blue dye ligand affinity chromatography, and size exclusion chromatography as has been reported previously (18) . After (Fig. 1) . On sodium dodecyl sulfate (SDS)-PAGE, peak IV was found to have molecular mass of -14,000 D and to be size homogeneous. Reverse-phase HPLC also revealed a single major protein peak. The other fractions were found to be heterogeneous by the above criteria. From 200 mg of starting fibril material -14 mg of peak IV was isolated, and it accounted for -20% of the solubilized isolated proteins.
Sequence analysis of peak IV material revealed a heterogeneous structure from which the parent molecule could not easily be identified. The cyanogen bromide fragmented material gave an HPLC profile that was indiscernible from non-FAP type I transthyretins (prealbumins). Sequence analysis ofthe major cyanogen bromide peptide provided a sequence that was identical to that from positions 14-52 of normal plasma transthyretin (prealbumin). Tryptic digestion of peak IV material generated a peptide mixture that gave the reverse-phase HPLC profile seen in Fig. 2 . In general, peptides were isolated in 90% or greater purity. Amino acid composition and sequence analysis revealed that these peptides were derived from plasma transthyretin (prealbumin): the only primary structure difference was that peptide TlO' (residues 81-103) was found to have a serine instead of the normal isoleucine at position 84 (Table I ). The amino terminal peptide started predominately from transthyretin (prealbumin) position 5, but longer and shorter peptides were also present. Finally, for a preparation from one ofthe brothers, peptide [7] [8] (residues 49-76) appeared to have both a glycine and the normal threonine at position 49. The two small peaks after peptides 10' and 10 had amino acid compositions and sequence analysis consistent with their being derived from 10' and 10 with arginine 104 attached to the carboxyl terminal. Se- Reverse-phase HPLC separation of peptides formed by tryptic digestion of 4 mg of amyloid subunit protein peak IV on a column (1 X 25 cm) of Synchrom RP-8 resin. The column was equilibrated in 0.1% trifluoroacetic acid and the peptides eluted with a linear gradient from 0 to 35% acetonitrile generated over 75 min. The flow rate was 2 ml/min and the column was maintained at room temperature. Peaks are numbered to correspond to the tryptic peptides as noted in Fig. 3 .
quenator yield data for all major peptides are shown in Table  II while the alignment of all peptides are shown in Fig. 3 .
Tryptic peptide HPLC maps for FAP type II and normal plasma transthyretin (prealbumin) can be seen in Fig. 4 . These profiles are identical except that the FAP type II protein has peak 10'. By sequence analysis this peak contains residues 81-103 of the transthyretin (prealbumin) molecule with a replacement at position 84 of a serine for the normal isoleucine.
Discussion
While large amounts of amyloid fibrils were isolated from the cardiac tissue, there was a low recovery of fibrils in the water supernatant, which is comparable with that seen for FAP type I tissue samples (1 1). To obtain the best yields of the subunit protein, solubilization in 8 M guanidine required 48-72 h to dissociate the fibril subunit proteins from the matrix proteins. Sequence analysis of peak IV material revealed a multiple sequence. Review ofthese data after further studies on the tryptic peptides revealed that this fraction was composed oftransthyretin (prealbumin) and that -40% of the material being sequenced started at position 5 of the transthyretin (prealbumin) molecule with an additional 20-30% starting at positions 4 and 6.
The cyanogen bromide digest was done on two samples of the amyloid subunit protein. The first cleavage was performed using subunit protein obtained from the top-layer material. Sequence analysis ofthe major cyanogen bromide polypeptide gave the same amino acid residues as the starting material, which indicates that little or no cleavage had occurred. However, when the cyanogen bromide digest was performed on the subunit protein isolated from the water wash material, the major peptide isolated by HPLC gave a single sequence starting at position 14 of the transthyretin (prealbumin) molecule. This sequence was extended to position 52 with no differences from normal transthyretin (prealbumin) ( Table II) .
The tryptic digest of the subunit protein from one of the brothers gave the profile seen in Fig. 2 . There are only a few differences in this profile from that of normal transthyretin (prealbumin). First, the amino terminal peptide (T 1) in the sub- Figure 3 . The complete amino acid sequence of the isolated amyloid subunit protein and the peptides used to determine the structure. Peptides labeled with a C were isolated after fragmentation with cyanogen bromide while those labeled with a T were isolated after trypsin digestion. All peptides are numbered sequentially from the amino terminus. The sequence information obtained from each peptide is represented by an arrow under the appropriate sequence.
unit protein elutes slightly earlier and is broader. This is most likely due to the facts that it is truncated and has a heterogeneous amino terminal. Second, peptide T2 (residues 10-15) was isolated in poor yields with limited recovery of carboxymethyl cysteine and methionine on amino acid analysis. Also, peptides T5-6 (residues 35-48) and T6 (residues 36-48) were isolated in very low yields (the small unlabeled peaks at 42 and 45 min, Fig. 2 ) and of insufficient purity for reliable sequence analysis. These findings are consistent with the cysteine 10, methionine 13, and tryptophane 41 all being partially or completely oxidized in the fibrils. That the subunit protein from top-layer fibril material did not show significant cleavage with cyanogen bromide is also consistent with oxidation ofthe methionine 13. This is in contrast to FAP type I fibrils, which show no such oxidation. This difference may be due to the tissue in which the fibrils are deposited. In most FAP type I preparations the fibrils are isolated from kidney, while in FAP type II the fibrils are isolated from the heart. Since the heart is a very oxygen-rich organ it is possible that long-term exposure to these levels of oxygen leads to oxidation of these sensitive residues. Coupled to this it can be proposed that those fibrils found in the water wash are more recently formed and have not yet been oxidized or tightly entangled in the cellular matrix.
The peptide for residues 81-103 was found in two peaks (TI0 and T10'). Peptide TI0 had the normal sequence while peptide TlIV had the same sequence but at position 84 the normal isoleucine had been replaced by a serine. Lastly, in one of the samples the peak for peptide T7-8 (residues 49-76) had a clearly observable shoulder, and on compositional analysis showed an extra half-residue ofglycine. Upon sequence analysis both glycine and threonine were seen at the amino terminus of this peptide (position 49), while all other residues were the same as normal.
If this were a real amino acid replacement it would represent a double substitution. This is of interest because it was initially reported that a Jewish hereditary amyloid also had a glycine at position 49 (10) . Sequence analysis of amyloid subunit protein from the second brother with FAP type II revealed no glycine at position 49. This, coupled to the fact that the cyanogen bromide sequence data only showed threonine at position 49, has led us to believe that the glycine is not part of the polypeptide backbone but instead is the result of a chemical linkage of a residue of glycine to an amino acid side chain (probably serine, threonine, or lysine).
In an attempt to confirm if the glycine residue is part of the primary structure or is attached to the prealbumin molecule either before or after its incorporation into the fibrils, we isolated transthyretin (prealbumin) from the plasma ofthe two deceased brothers, two clinically proven affected family members, and four children ofclinically affected individuals as well as ofnormal individuals. For all individuals the yield ofisolated transthyretin (prealbumin) was 35-45% of theoretical, which is the range we have seen for this method (18) . Because of the high stability of transthyretin (prealbumin) it is necessary to denature the protein before trypsin digestion. For these proteins we used the method of Nakazato et al. with incubation in 70% formic acid at room temperature for 18 h (19). We found this method acceptable, but only 20-40% ofthe molecules were fragmented with trypsin in this manner. To ascertain that neither the normal or variant protein was preferentially cleaved by trypsin, the undigested proteins from preparations of two affected individuals were redigested with trypsin. HPLC peptide profiles of these materials showed essentially complete cleavage and did not differ significantly from the first trypsin-digested material. The pattern for the two deceased brothers and two affected family members is seen in Fig. 4 A while the pattern for normal transthyretin (prealbumin) is seen in Fig. 4 B. For both profiles, the patterns are identical except in the affected individuals where peak TlIO is observed. Sequence analysis reveals that this is peptide 81-103 with a serine for isoleucine at position 84. Sequence analysis of peptide 7 and 7-8 both show only threonine at position 49 for all individuals tested. Since peptides T2, T5-6, and T6 were isolated in good yields from the plasma transthyretin with no loss of cysteine, methionine, and tryptophan, this is consistent with the loss of these residues in the fibril subunit protein being due to tissue oxidation.
From these studies it would seem that the glycine that appears to be at position 49 is not part of the primary structure and that it is not attached to transthyretin (prealbumin) in the plasma. It is possible that the residue is attached after the fibrils are deposited into the tissue and that this modification may be tissue specific. This would explain the presence of the adduct in some amyloid-laden tissues but not in others as has been reported in the amyloid of Jewish origin (16, 19) .
For the four presymptomatic individuals whose transthyretin (prealbumin) were studied, two of them had peptide TlOV and two did not. Prior studies show that affected individuals in this kindred have low RBP levels, which was true for the two presymptomatic individuals who had peptide TlO'. Therefore, it appears that the occurrence of low plasma RBP levels is associated with the position 84 substitution and may be used to identify carriers of the abnormal gene. (12) .
From the x-ray structure of the transthyretin (prealbumin) molecule it has been determined that position 84 is located on an external loop on the outer surface of the protein between beta sheet strands E and F (20) . This position is on one of the most exposed segments of the molecule, and how this substitution leads to the formation of fibrils is uncertain. However, certain features would appear to be important. Position 84 is at the end of a short alpha helical region (positions 78-83) and a mutation from isoleucine to serine will have effects on hydrophobicity and hydrogen bonding. Since low ionic strength is known to dissociate transthyretin (prealbumin) and RBP, it would appear that hydrophobic interactions may play an important role in the association of these proteins (21). Thus, the replacement of isoleucine at position 84 with a serine would lead to a major reduction of hydrophobicity in this region and may lead to a higher dissociation constant for these proteins. This reduced affinity for RBP could explain the low serum levels of RBP because unbound to transthyretin (prealbumin) it is quickly cleared by the kidneys (22) . How the serine at position 84 will alter the protein structure will have to await x-ray structure analysis of the variant protein.
From the genetic code and transthyretin (prealbumin) complementary DNA (cDNA) sequence it is clear that the change from isoleucine to serine involves a single base substitution where the second codon is changed from a uracil (thymine) to a guanine (23) (24) (25) . This replacement of a purine for a pyrimidine base should alter the DNA so that specific nucleases will give different patterns for the normal and variant genes. Thus, it should be possible to identify carriers ofthis trait by differences in restriction nuclease patterns as has already been shown for the methionine for valine substitution in FAP type I individuals (26) and for alanine for threonine substitution in FAP Appalachian (27) .
